Brief: Castle Announces Early Exploratory Study Data For Potential Development Of A Complementary Test To Accompany Decisiondx-Um
Nov 3 (Reuters) - Castle Biosciences Inc CSTL.O :
* CASTLE ANNOUNCES EARLY EXPLORATORY STUDY DATA FOR
POTENTIAL
DEVELOPMENT OF A COMPLEMENTARY TEST TO ACCOMPANY DECISIONDX®-UM
THAT COULD AID IN THE EARLY DETECTION OF UVEAL MELANOMAS
Source text for Eikon: ID:nBw76RMpRa
Further company coverage: CSTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million